Auxora’s Effect on Severe COVID-19 Request More Information Trial Objective Researchers want to know if the experimental drug Auxora™ can be used as a safe and effective treatment for patients diagnosed with severe COVID-19 with pneumonia. Participants in the study will either be given Auxora or a placebo, a pill containing no medication, to understand effects of the medication. The medication or placebo will be given once a day for three days to patients hospitalized with severe COVID-19. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate People who are admitted to Saint Joseph Hospital with a positive COVID-19 test result and who have symptoms of the coronavirus may be eligible to participate in the study. Age: 18+ Gender: Any Gender Estimated Time Commitment Up to 30 days Including the time a participant is hospitalized and up to two follow-up phone calls after being discharged from the hospital. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Christine Griesmer 303.398.1325 Request More Information Trial Location National Jewish Main Campus and Saint Joseph Hospital, Denver, CO Trial Sponsors CalciMedica, Inc. Principal Investigators William Janssen, MD + × William Janssen, MD Section Head, Critical Care Medicine Professor of Medicine Section of Critical Care Medicine Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Make an Appoinment Co-Investigators Elaine Schwartz, MD, FCCP + × Elaine Schwartz, MD, FCCP Professor Medical Director, National Jewish Critical Care Service at Rose Medical Center Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Make an Appoinment Peter Stubenrauch, MD + × Peter Stubenrauch, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Request More Information Complete this form to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:*
Trial Objective Researchers want to know if the experimental drug Auxora™ can be used as a safe and effective treatment for patients diagnosed with severe COVID-19 with pneumonia. Participants in the study will either be given Auxora or a placebo, a pill containing no medication, to understand effects of the medication. The medication or placebo will be given once a day for three days to patients hospitalized with severe COVID-19.